Head fat is a novel method of measuring metabolic disorder in Chinese obese patients by Xing-chun Wang et al.
Wang et al. Lipids in Health and Disease 2014, 13:113
http://www.lipidworld.com/content/13/1/113RESEARCH Open AccessHead fat is a novel method of measuring
metabolic disorder in Chinese obese patients
Xing-chun Wang1,2, Huan Liu2, Yue-ye Huang1, Hang Sun1, Le Bu1 and Shen Qu1,2*Abstract
Background: Body adiposity, especially ectopic fat accumulation, has a range of metabolic and cardiovascular
effects. The aim of this study was to investigate the association between head fat and metabolic values in Chinese
obese patients.
Methods: Data of this cross-sectional study from 66 obese patients were collected. Fat distribution was measured
by dual-energy X-ray absorptiometry, and data of body weight, body mass index (BMI), neck circumference (NC),
waist circumference (WC), hip circumference (HC), visceral index, basal metabolism (BM), glucose metabolism, lipid
levels, uric acid (UA) had been collected.
Results: 1) Head fat was significantly associated with BMI, WC, HC, visceral index, BM, total fat and total fat
excluding head fat in both males and females (p < 0.05). Head fat was positively correlated with upper limb fat,
trunk fat, weight, fasting plasma C peptide, fasting plasma insulin and UA in women(p < 0.05), and the association
was not statistically significant in male (p > 0.05). Head fat was positively corrected with NC in males (p < 0.05) but
not females (p > 0.05). There was no significant correlation between head fat and fasting plasma glucose, total
choleslerolemia, triglyceridemia, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and free
fat acid in either gender (p > 0.05). 2) Receiver operating characteristic analysis showed that a head fat of 1925.6 g
and a head fat of 1567.85 g were the best cut-off values to determine subjects with low high-density lipoprotein
cholesterol and hyperuricemia respectively.
Conclusions: Head fat accumulation was closely associated with increased body fat, hyperinsulinemia, hyperuricemia,
and impared lipid profile, suggesting it might be used as an indicator for dyslipidemia and hyperuricemia.
Keywords: Obesity, Head fat, Regional fat, Lipid profile, HyperuricemiaBackground
Obesity is a public health problem that has become a
global epidemic. According to the World Health
Organization (WHO), there will be about 2.3 billion
overweight people aged 15 years and above, and over
700 million obese people worldwide in 2015. Substantial
literature has emerged to show that overweight and
obesity are major causes of co-morbidities, including type
II diabetes mellitus (T2DM), hyperlipidemia, hyperurice-
mia and cardiovascular disease. Body adiposity, especially
ectopic fat accumulation, has a range of metabolic and
cardiovascular effects.* Correspondence: qushencn@hotmail.com
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unless otherwise stated.Previous studies have already shown that overweight or
obese patients who have the same amount of total body
fat may have different risk factor profiles [1]. Therefore,
regional fat distribution is better than the total fat in the
prediction of cardiovascular disease and metabolic disease.
As we know, the accumulation of abdominal fat also
called central obesity is strongly associated with meta-
bolic syndrome, T2DM, and cardiovascular disease [2-4].
Excess abdominal visceral adiposity is the key correlate
of metabolic syndrome and upper body fat distribution
is commonly associated with increased visceral fat and
an abnormal metabolic profile [5-8]. In addition, previous
data also suggest that fat accumulation peripherally
such as in the lower extremities is inversely associated
with adiposity-related biological factors and risk of
metabolic syndrome [9]. The regional obesity also relatestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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fat is one of risk factors of OSAS, and a predictor of the
severity of OSAS [10]. Additionally, neck circumference
(NC), which mainly reflects the fat deposit around
respiratory tract or subcutaneous fat in the neck, is a
proxy for upper-body fat and a reliable screening measure
for the identification of patients with abnormal fat dis-
tribution. NC can be used as a marker to reflect central
obesity and cardio-metabolic syndrome [11-13].
The relationship between regional fat accumulation of
head fat and metabolic risks in obese patients remains
unknown. Thus, we conducted this study to investigate
whether head fat is related to regional fat distribution,
metabolic values, and whether head fat can as used as a
predictor for dyslipidemia, impaired fasting glucose,
hyperinsulinemia and hyperuricemia in obese Chinese
patients.
Results
Baseline characteristics of patients
The study sample consisted of 66 patients, 20 (30.3%) male
and 44 (69.7%) female, with a mean age of 30.78 ± 9.66 years
and a mean head fat of 1696.01 ± 336.10 g. The main char-
acteristics of the study populations were shown in Table 1.
There were significant differences in body weight, waist
circumference (WC), visceral index, basic metabolism (BM)
and total fat% between men and women (p < 0.01). Other
anthropometry and metabolic variables were not signifi-
cantly different between the genders (p > 0.05).
Correlation of head fat with anthropological and
metabolic variables
Head fat was significantly associated with body mass
index (BMI), WC, HC, visceral index, BM, total fat and
total fat excluding head fat in both male and female
(Table 2). Head fat was positively correlated with upper
limbs fat, trunk fat, weight, fasting plasma C peptide,
fasting plasma insulin in women, and the association
was not statistically significant in male (Table 2). Head
fat was positively corrected with NC in male (r = 0.667,
p < 0.05) but not female. There was not significant cor-
relation between head fat and fasting plasma glucose
(FPG), total cholesterol (TCH), triglyceride (TG), high
density lipoprotein-cholesterol (HDL-C), low density
lipoprotein cholesterol (LDL-C) and free fat acid (FFA)
in both genders (p > 0.05) (Table 2).
Optimal cut-off points of head fat for abnormal lipid
metabolism
The prevalence of high TG was 61.82%. Area under the
receiver operating characteristic curve (ROC) was 0.641
for predicting high TG (p = 0.077). The prevalence of
high LDL-C was 48.07% and area under the ROC curve
was 0.493 for predicting high LDL-C (p = 0.941). Theprevalence of high TCH was 32.14% and area under the
ROC curve was 0.473 for predicting high TCH (p > 0.05).
The prevalence of low HDL-C was 38.89%. 1925.6 g
emerged as the optimal cut-off point of head fat for low
HDL-C with a sensitivity of 57.1%, a specificity of 93.9%
and the area under the ROC curve was 0.752 (p = 0.002,
95%CI: 0.613 ~ 0.890) (Table 3).
Optimal cut-off points of head fat for IFG and
hyperinsulinemia
The prevalence of impaired fasting glucose (IFG) was
22.95% in this obese population. Area under ROC curve is
0.553 (p = 0.548). The prevalence of hyperinsulinemia was
71.67% and area under ROC curve is 0.605 (p = 0.209).
Optimal cut-off points of head fat for hyperuricemia
The prevalence of hyperuricemia was 67.74% in females.
1572.75 g was an optimal cut-off point of head fat for
hyperuricemia with a sensitivity of 71.4%, a specificity
of 80% and the area under the ROC curve was 0.738
(p = 0.035, 95%CI: 0.557 ~ 0.919) (Table 4). The preva-
lence of hyperuricemia was 38.89% in males and area
under the ROC curve was 0.390 (p = 0.441).
Discussion
Obesity is a public health problem that has raised concern
worldwide. Accumulating evidence shows that regional
fat distribution is a clinical indicator for the risk of
T2DM and cardiovascular disease. Few articles focus
on the association between head fat accumulation and
metabolic disorders. In this study, we demonstrated that
the regional accumulation of fat around the head was
associated with classic obesity markers such as BMI,
WC, HC, visceral index and BM in both genders. Head
fat was also positively correlated with total fat, total fat
excluding head fat, upper limb fat and trunk fat in females.
Additionally, head fat correlated positively with fasting
insulin, fasting C peptide and UA in female. We further
revealed head fat might be a predictor for metabolic
abnormalities including low HDL-C and hyperuricemia.
Receiver operating characteristic analysis showed that a
head fat of 1925.6 g was the best cut-off point to determine
subjects with low HDL-C and a head fat of 1567.85 g was
the best cut-off point to determine subjects with hyperuri-
cemia in female. These results not only further confirmed
the clinical significance of NC but also the metabolic
impact of regional fat accumulation in the head.
Previous studies have shown that NC which represents
neck fat deposit is a reliable anthropometric index to indi-
cate central obesity [14]. In this study, we showed that
head fat correlated positively with total fat and total fat
excluding head fat in both genders. Additionally, head
fat is closely related to upper limb fat and trunk fat in
females. These results showed that head fat might also
Table 1 Baseline study sample characteristics according to genders
Parameters Men Women p-value
Number 20 46
Age, years old 29.45 ± 8.65 31.37 ± 10.10 0.463
Head fat, g 1829.43 ± 337.66 1638.01 ± 321.99 0.032
Body weight, kg 102.13 ± 19.74 83.37 ± 12.07 0.001
BMI, kg/m2 33.24 ± 4.46 31.85 ± 4.25 0.234
NC, cm 42.01 ± 4.66 38.30 ± 9.54 0.133
WC, cm 109.58 ± 14.69 99.50 ± 8.59 0.002
HC, cm 112.79 ± 11.13 107.48 ± 8.25 0.049
Visceral index 17.64 ± 6.37 12.19 ± 5.73 0.002
BM, kcal 2062.22 ± 339.91 1623.66 ± 189.49 <0.001
FPG, mmol/l 5.80 ± 1.75 5.43 ± 1.40 0.397
Fasting insulin, uU/ml 24.42 ± 13.78 23.75 ± 11.32 0.841
Fasting CP, ng/ml 3.85 ± 1.38 3.51 ± 1.26 0.358
TCH, mmol/L 4.90 ± 1.29 4.97 ± 0.96 0.824
TG, mmol/L 1.79 ± 0.78 1.75 ± 1.59 0.925
HDL-C, mmol/L 1.06 ± 0.26 1.24 ± 0.31 0.053
LDL-C, mmol/L 2.86 ± 1.22 2.84 ± 0.68 0.939
FFA, mmol/L 0.61 ± 0.22 0.61 ± 0.28 0.977
UA, umol/L 442.64 ± 92.08 368.43 ± 103.09 0.014
Upper limbs fat, g 5328.93 ± 1274.17 5493.33 ± 1304.78 0.637
Lower limbs fat, g 9843.77 ± 2838.54 10430.69 ± 2948.71 0.455
Total limbs fat, g 15172.70 ± 3746.38 15924.02 ± 3891.50 0.469
Trunk fat, g 17554.45 ± 3782.72 16420.15 ± 3596.75 0.251
Total fat except head, g 32731.45 ± 6787.01 32347.40 ± 6747.21 0.833
Total fat, g 34516.35 ± 6987.79 33989.90 ± 6875.77 0.758
Total fat, % 34.72 ± 4.41 41.30 ± 4.28 <0.001
BMI, body mass index; NC, neck circumference; WC, waist circumference; HC, hip circumference; BM, basic metabolism; FPG, fasting plasma glucose; TCH, total
cholesterol; TG, triglyceride; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lipoprotein cholesterol; FFA, free fat acid; UA, uric acid.
Continuous data were described as means ± standard deviation.
p-values < 0.05 were considered significant.
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The association between head fat and other regional fat
was not significantly in males, probably because of the
limited sample size.
The association between head fat and other regional
fat indicated the importance of the head fat in predicting
upper body fat, thus head fat might be used as a contri-
butor to cardiometabolic risk. As we known, increased
regional lipid content in the liver and muscle are associated
with insulin resistance [15,16]. NC is not only associated
with obesity and regional fat distribution, but also can be
used for clinical screening of insulin resistance in high risk
populations [17,18]. The analysis of our study revealed
head fat was correlated positively with fasting insulin and
fasting C peptide in females, suggesting head fat deposit
might be a key feature of hyperinsulinemia and insulin
resistance.Elevated UA is a strong risk factor for cardiovascular
disease and it plays an important role in the development
of metabolic syndrome [19-21]. Studies indicate that
weight gain is a risk factor for hyperuricemia while weight
loss reduces the risk [22]. Hyperuricemia may be affected
by differences in body fat distribution in obesity [23]. A
previous study showed visceral fat may have a greater
adverse effect on the metabolism of UA than BMI or
subcutaneous fat [24]. Epicardial adipose tissue (EAT)
thickness in children is associated with hyperuricaemia
[25]. Similarly, our study also showed head fat was
correlated with UA in female and 1572.75 gs is optimal
cut-off point of head fat for hyperuricemia in females.
In addition, previous studies have shown that visceral
fat mass is associated with elevated TG in obese women
[26]. Visceral fat area has high positive correlations with
TG level and a negative correlation with the HDL-C
Table 4 Comparison of sensitivity, specificity, Youden
index of uric acid with different head fat point
Head fat (g) Sensitivity (%) Specificity (%) Youden index
1402.10 90.5 20.0 0.105
1528.00 81.0 60.0 0.410
1550.05 76.2 70.0 0.462
1572.75 71.4 80.0 0.515
1829.80 38.1 100.0 0.381
Table 2 Correlation of head fat with anthropological
metabolic variables and fat distribution
Head fat
Men Women
r p-value r p-value
Body weight, kg 0.540 0.014 0.607 <0.001
BMI, kg/m2 0.605 0.005 0.500 <0.001
NC, cm 0.667 0.003 −0.026 0.874
WC, cm 0.636 0.005 0.557 <0.001
HC, cm 0.637 0.004 0.415 0.008
Visceral index 0.699 0.001 0.568 <0.001
BM, kcal 0.599 0.007 0.623 <0.001
FPG, mmol/l 0.183 0.468 0.201 0.191
Fasting insulin, uU/ml 0.303 0.236 0.397 0.008
Fasting CP, ng/ml 0.496 0.051 0.396 0.010
TCH, mmol/l −0.034 0.904 0.178 0.265
TG, mmol/l 0.264 0.341 0.153 0.225
HDL-C, mmol/l −0.517 0.071 −0.235 0.138
LDL-C, mmol/l 0.346 0.298 0.200 0.211
FFA, mmol/l −0.349 0.222 0.064 0.689
UA, umol/L 0.635 0.036 0.455 0.003
Upper limbs fat, g 0.502 0.024 0.533 <0.001
Trunk fat, g 0.546 0.013 0.420 0.004
Lower limbs fat, g 0.436 0.055 0.133 0.387
Total limbs fat, g 0.501 0.024 0.280 0.060
Total fat except head, g 0.581 0.007 0.386 0.008
Total fat, g 0.612 0.004 0.425 0.003
For list of abbreviations, see Table 1.
p-values < 0.05 were considered significant.
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such as leg fat mass is favorably associated with cardio-
metablic risks factors [28,29]. NC what presents for
peripheral fat of neck fat is associated with serum TCH,
TG, increased LDL-C and decreased HDL-C in healthy
adults [30]. Studies have also shown that NC is corrected
with decreased HDL–C and increased TG [31-33].Table 3 Comparison of sensitivity, specificity, Youden
index of high density lipoprotein cholesterol with
different head fat point
Head fat (g) Sensitivity (%) Specificity (%) Youden index
1409.65 95.2 18.2 0.134
1577 90.5 48.5 0.39
1607.65 85.7 51.5 0.372
1644.55 76.2 57.6 0338
1668.25 66.7 63.6 0.303
1822.1 61.9 84.8 0.467
1925.6 57.1 93.9 0.51Additionally, other studies reported that increased upper
body subcutaneous fat is associated with increased LDL-C
and decreased HDL-C [34]. The association between head
fat and lipid levels in our study was not obvious. However,
data analysis on lipid levels showed the prevalence of high
TG, high LDL-C and high TCH were 61.82%, 48.07% and
32.14% respectively. The prevalence of low HDL-C was
38.89% and 1925.6 g emerged as optimal cut-off point of
head fat for low HDL-C.
There were some limitations in this study. Firstly, the
primary limitation of this study was the use of a cross-
sectional design. Therefore, we cannot infer causality from
our results. Secondly, the sample of the present study was
relatively small. Finally, our result might not be applied to
other racial or age groups because the studied subjects
were predominantly Chinese adults. Therefore, further
studies are necessary to prove these conclusions in larger
sample size and with longitudinal studies.
Conclusions
This study demonstrated that head fat was significantly
associated with metabolic values among Chinese adults.
Besides, receiver operating characteristic analysis showed
the cut-off point of head fat to determine subjects with
low HDL-C and hyperuricemia. Our findings might pro-
vide new insight into the role of head fat accumulation
in the development of obesity-related diseases.
Methods
Sample population
A cross-sectional survey based on data from outpatient of
Shanghai Tenth People’s Hospital was conducted among
obese patients with BMI over 28 kg/m2 who had been
seen in clinic between September 2011 and December
2013. The inclusion criteria included: 1) patients diagnosed
with obesity (Obesity was defined as BMI ≥ 28 kg/m2) and
2) patients aged from 18–60 years old. People with medical
illnesses such as clinical or laboratory evidence of cardiac,
renal, liver or severe systemic diseases (e.g., cancer and
heart failure) were excluded. A total of 229 obese subjects
with measurement of dual-energy X-ray absorptiometry
were enrolled for analysis. In addition to DEXA measure-
ment, physical examination, including NC, WC, HC, and
body weight, BMI, viscera index, BM, all subjects also
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fasting insulin, fasting C peptide, TCH, TG, HDL-C, LDL-
C, FFA and UA. We excluded those patients lacking appro-
priate data (n = 163). After the appropriate exclusions, data
of 66 patients were included in our analysis. The study
protocol was approved by the ethics committee of Shanghai
Tenth People's Hospital and written informed consent was
obtained from each participant.
Anthropometry
Weight, BMI, visceral index and BM were measured with
light clothes and without shoes by Omron HBF-358
(Q40102010L01322F, Japan). WC was measured at the
level midway between the lower rib margin and the iliac
crest. NC was measured with head erect and eyes facing
forward, horizontally at the upper margin of laryngeal
prominence (Adam’s apple). HC was measured at the full-
est point around the buttocks. These parameters were
measured twice and the average was used for analysis.
DEXA measurement
Body composition was measured using DEXA (Hologic
QDR4500, USA). DEXA is a method for testing body com-
position and has high accuracy and good reproducibility,
and is especially accurate for the determination of fat
content and fat distribution [35]. DEXA was measured
with the patient in the supine position. DEXA data
including total fat%, upper limbs fat, lower limbs fat,
trunk fat, total fat except the head, total fat, head fat.
We calculated total fat in each limb.
Lab testing
Blood samples were obtained after fasting over 8 hours
for the measurement of lab testing including fasting plasma
glucose, fasting insulin, fasting C peptide, TCH, TG, HDL-
C, LDL-C, FFA and UA.
Definition of dyslipidemia, impaired fasting glucose
tolerance hyperinsulinemia and hyperuricemia
In this study, high TG was defined as fasting plasma
TG ≥ 1.7 mmol/L, low HDL-C was defined as fasting
HDL-C < 1.04 mmol/L,high LDL-C was defined as LDL-
C ≥ 3.37 and high TCH was defined as TCH ≥ 5.18 mmol/L
[36]. IFG was defined as fasting plasma glucose ≥
5.6 mmol/l [37]. Hyperinsulinemia was defined as fasting
plasma insulin ≥15 mU/L [38]. Hyperuricemia was defined
as serum uric acid concentration ≥ 7 mg/dl (≥417 umol/L)
in men, and ≥ 6 mg/dl (≥357 umol/L) in women [39].
Statistical analysis
All data were analyzed using SPSS 17.0 software. All con-
tinuous data are presented as means ± standard deviation
(SD). Quantitative data were analyzed by t-test between
the two groups, the correlation between different variableswere assessed using correlation analysis. ROC analyses
was performed to assess the accuracy of head fat as diag-
nostic tests for dyslipidemia, IFG, hyperinsulinemia and
hyperuricemia to determine optimal head fat cut-off in
relation to dyslipidemia and hyperuricemia. Youden index
(sensitivity + specificity −1) was used for determining the
head fat cut-off point. All tests of significance were two
tailed with a value of p < 0.05.
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